End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
2,80,500 KRW | -1.41% |
|
-0.18% | +184.77% |
2023 | Alteogen Inc. Announces Clinical Trial of Tergase Showed Zero Incidence of ADA | CI |
2023 | ALTEOGEN Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
ETFs positioned on ALTEOGEN Inc.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.64% | 2 M€ | -14.14% | ||
0.02% | 4 M€ | -4.41% | - | |
0.01% | 7 M€ | +3.51% | - | |
0.00% | 114 M€ | +5.50% | - | |
0.00% | 36 M€ | +10.49% | - | |
0.00% | 324 M€ | +8.15% | - | |
0.00% | 40 M€ | +7.33% | - | |
0.00% | 32 M€ | +4.52% | - | |
0.00% | 7 M€ | +0.11% | - |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+184.77% | 1.08TCr | |
+2.99% | 9.52TCr | |
-4.34% | 3.75TCr | |
-10.41% | 3.38TCr | |
+75.79% | 2.82TCr | |
-14.61% | 1.56TCr | |
-3.46% | 1.36TCr | |
-12.31% | 1.15TCr | |
-54.13% | 923.34Cr | |
+6.22% | 909.4Cr |
- Stock Market
- Equities
- A196170 Stock
- Funds and ETFs ALTEOGEN Inc.